EPO and chronic kidney disease: A recent clinical trial with 100 patients with CKD used EPO subcutaneous injections plus acupoint application (the medicinal ingredients: Astragalus, Eucommia, Dipsacus, raw rhubarb, Angelica, motherwort, Chuanqiong, raw oysters, Radix Aconiti) at Zusanli (ST36), Geshu (BI17), Pishu (BI20), and Shenshu (BI23) for 2 months; the patients demonstrated an increase in Hb and Hct levels in the acupoint application group, surpassing those in the control group (113).